# Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

> **NCT01240824** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Virginia** · enrollment: 3 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** aminophylline

## Key facts

- **NCT ID:** NCT01240824
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2014-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240824, "Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01240824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*